Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Health Care Sector
#6
AbbVie is something that was on the back of my mind to research, but even though Im tempted - Im not ready to buy in without doing my due diligence. GILD is benefiting a lot with ABBV's fall since that will boost their HepC drug instead.

I own JNJ as well and to complement, I own AMGN - which has more of a focus on inflammation, oncology and nephrology drugs.

FYI, GILD's focus is on HepC and HIV drugs.
Reply


Messages In This Thread
Health Care Sector - by EricL - 10-05-2015, 10:32 AM
RE: Health Care Sector - by Dividendsrule - 10-05-2015, 12:31 PM
RE: Health Care Sector - by Rasec - 10-05-2015, 01:06 PM
RE: Health Care Sector - by benjamen - 10-23-2015, 06:23 AM
RE: Health Care Sector - by DividendGarden - 10-23-2015, 09:11 AM
RE: Health Care Sector - by EricL - 10-23-2015, 09:51 AM
RE: Health Care Sector - by Roadmap2Retire - 10-23-2015, 09:12 AM
RE: Health Care Sector - by Rasec - 10-23-2015, 10:01 AM
RE: Health Care Sector - by EricL - 10-23-2015, 10:57 AM



Users browsing this thread: 2 Guest(s)